acetylsalicylic acid
Commercial- Indications
- Injectable formulation
Company intelligence / Profile preview
Leman SKL Pharmaceuticals
Geneva / Petit-Lancy, Geneva, Switzerlandleman-skl.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Leman SKL develops and globally markets approved generic and established branded pharmaceuticals for hospital and outpatient care, with core strengths in dermatology and a broadened portfolio including antibiotics, oncology, and other therapeutic areas. All medicines are approved by Swissmedic and European regulators; recent Swiss authorization for import/distribution of injectable acetylsalicylic acid due to shortages.
- Therapeutic areas
- RheumatologyPsychiatryMen's HealthInfectious DiseasesGastroenterologyDermatologyCardiovascularOtherOncologyWomen's Health
- Modalities
- Small moleculeGeneric drugsBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Leman SKL Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leman SKL Pharmaceuticals.